The Gold Standard Executive Order Explained, and the Hard Part That Comes Next

Since roughly the turn of the year, the political operation inside this administration has been working to get vaccines off the table until after the midterms. For those of us who have spent years on the vaccine issue, this has been a very disappointing few months.

Monday’s executive order ended it.

The Wall Street Journal reported in late July that Trump had been pressing Kennedy privately the whole time to move faster rather than slower. Then the President signed the thing himself, in his own name, roughly ninety days before an election his own pollster warned him about.

Whatever else it accomplishes, it put vaccines back at the center of the national conversation over the objection of his advisors. Pro-vaccine forces may end up pleased about that, on the theory that it helps Democrats take back Congress. Even so, the President chose what he believes about vaccines over what was politically expedient. So good on him!

The EO is wonderful news for those on this side of the issue, but let’s be clear-eyed about what it does, and does not do.

The bottom line in six questions and answers

Is the executive order a big deal? Yes, big picture-wise, but operatively, probably not so much in the short term anyway.

Does it change the childhood vaccine schedule, or what your child needs to enroll in school? No. Not today, not in ninety days, and not until something else big happens.

Does the executive order trump the Murphy ruling in AAP v. Kennedy? No.

Does it undo the injunction against the January 2026 schedule changes? No.

Where does the federal schedule stand right now? Where it stood last Friday.

Does the order automatically take effect? No. There is nothing in the EO that parents will feel immediately in terms of vaccine mandates or religious exemptions to school mandates. It does not change anything a state mandates for schools.

Let’s go deeper and explain

A president cannot dissolve a federal court injunction by signing a different document. Judge Murphy’s March 16 preliminary injunction runs against Secretary Kennedy, HHS and CDC. Those are the parties. The President is not one of them, and he cannot direct his subordinates to do what a court has forbidden them to do.

The order acknowledges this in its own preamble, which states that implementation of the prior directives “has been delayed due to litigation over the composition of the Advisory Committee on Immunization Practices and separate updates to the Federal vaccine schedule.” The White House drafted around the injunction rather than through it.

The structural problem is the one I described in March. Murphy held that the CDC Director cannot revise the schedule unless ACIP originates the change, and then he stayed nearly every ACIP appointment. The Director cannot act alone and the committee cannot function. I opposed that injunction and I still think Murphy got it wrong on a one-sided record, but it is the law of that case until a higher court changes it.

Everything with immediate legal consequence runs through that same channel. First-dollar insurance coverage under the Affordable Care Act keys to an ACIP recommendation adopted by the CDC Director. So does eligibility under Vaccines for Children. A presidential declaration does not reach either one.

As for the ninety days, the order gives the Secretary that long to bring plans to the President covering vaccine timing and sequencing, continuous evaluation of risk and benefit, and improved safety monitoring, transparency and research. Plans, not schedules. Ninety days from Monday is early November.

State school mandates are a separate legal system. They are state police power and no executive order preempts them. States have also been walking away from the federal recommendations on their own initiative. California de-linked last year with AB 144, stripping ACIP references out of more than twenty-five statutes and freezing its baseline at January 1, 2025.

And the gap between recommendation and requirement was always wider than people assume. The federal schedule covered (more or less) eighteen diseases. California mandates ten for school. Massachusetts is at nine for kindergarten through twelfth grade. No state ever required what the federal (or American Academy of Pediatrics) schedule recommended.

Where the order will actually be felt

In the exam room, and sooner than anywhere else.

It puts a signed federal document behind what families have been saying for years, that influenza and COVID are shared clinical decisions and that spacing shots across separate visits is a legitimate choice rather than a character defect. That matters in a conversation with a pediatrician, and it matters more if a refusal ever escalates into a medical neglect referral or a custody dispute.

It is also worth asking your pediatrician which schedule she means. From 1995 through 2024 the American Academy of Pediatrics co-authored and formally endorsed the federal childhood schedule. One document, one process, three decades. The Academy left that process in 2025 and published its own schedule that August. So the eighteen-disease schedule families are told they must follow is now the AAP’s own product, a year old, carrying the Academy’s name and nobody else’s.

Two cautions when you use the order. The CDC schedule in force is still the old one, so cite the order as a statement of federal policy and do not claim the schedule changed. And it does not stop a practice from dismissing you. A 2019 national survey found 51 percent of pediatricians reported their office had a policy of dismissing families who refused the primary series, and the AAP’s own 2024 clinical report concedes that evidence is lacking on whether such policies affect vaccination rates at all, and lacking on where dismissed children end up. On dismissal from the practice, the better authority is the American Medical Association, which says a physician should not refuse a patient solely because the individual declines vaccination, though it carves out situations where an unvaccinated patient would pose significant risk to other patients in the practice.

Can Washington withhold money from the holdout states?

Less than people think, and California shows why.

Roughly $174 billion a year flows through California’s state budget from Washington, about 35 percent of the total, and around $119 billion of that is Medi-Cal. In NFIB v. Sebelius the Supreme Court held, (simplifying), that the federal government cannot hold the entire Medicaid grant hostage to force a state into something that is not Medicaid. That might have been the first time in history the Court struck down a spending condition as coercive.

Money small enough to condition lawfully carries a different constraint. Federal K-12 funding for California runs about $8 billion, roughly 1.6 percent of the state budget, well inside what the Court has allowed. But it flows from congressional legislation, and the executive branch has had a hard time attaching conditions to statutes Congress wrote without them. The one pot obviously available for a vaccine condition is the CDC immunization grant program, six to eight hundred million dollars a year across sixty-four grantees nationwide, which is not a number that moves a state legislature.

Investigation authority is the better question, and those tools sit at DOJ and the HHS civil rights office. Both can open compliance reviews without waiting for anyone to file anything. California’s medical exemption review process is exposed to that today.

The Task Force

The resuscitation of the Task Force tasked with apprising Congress about vaccines is a direct result of a federal action filed in May 2025 by my friend and colleague Ray Flores, Esq., funded by Children’s Health Defense, to restore the Task Force on Safer Childhood Vaccines. HHS revived it that August, with NIH Director Bhattacharya as chairman.

The Task Force exists under 42 U.S.C. § 300aa-27, the safer-vaccines mandate in the 1986 Act. That statute directs the Secretary to promote development of childhood vaccines producing fewer and less serious adverse reactions, and to make improvements in licensing, manufacturing, testing, labeling, warning, use instructions, distribution, administration, field surveillance and adverse reaction reporting.

Labeling, warnings and use instructions are squarely within that authority. So the realistic near-term output is package insert changes, expanded contraindications, and a rebuilt adverse event reporting system. None of that requires ACIP and none of it is touched by Murphy’s injunction. Of everything the order sets in motion, that is the track with the clearest path, and it is where I would look over the next ninety days, for recommendations at least.

One structural detail. The Task Force is composed entirely of full-time federal officers, which likely places it outside the Federal Advisory Committee Act and therefore outside the defect that sank the reconstituted ACIP. I doubt that was accidental.

Is something coming on autism?

I have been asked whether the order is clearing a runway for federally funded findings on vaccines and autism. I do not know, and I would be guessing.

What I can say is what is funded. There is one federal study looking at vaccines and autism, a sole-source contract the CDC awarded to Rensselaer Polytechnic Institute last September. Secondary reporting puts it at about $362,000, closing September 29 of this year, with Juergen Hahn as principal investigator, and the university has said he intends to publish at the conclusion. The rest of the portfolio points elsewhere. The $50 million NIH put into autism research last September went to thirteen projects on pesticides, air pollution, maternal nutrition, perinatal complications and immune responses during pregnancy, running on two and three-year clocks into 2027 and 2028.

What the order does build is the channels. The Task Force reports to Congress under the 1986 Act. The reconstituted Interagency Autism Coordinating Committee, which Kennedy repopulated in January with twenty-one new members, publishes a strategic plan and meets again on August 27. Neither route runs through ACIP, which means neither is touched by the injunction.

What the EO does: the three categories

The order sorts childhood vaccines into three groups.

Eleven diseases are recommended for all children: measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Hib, pneumococcal disease, HPV and varicella. A second group is recommended for high-risk populations, covering RSV monoclonal antibody, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY and dengue. A third moves to shared clinical decision-making, covering hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza and COVID-19.

Hepatitis A and hepatitis B each appear in two groups, as does meningococcal disease under two different names, so the categories are not mutually exclusive as drafted.

The placement of hepatitis B is worth noting for anyone comparing this to state law. It sits outside the universal group while HPV sits inside it. Every state that mandates school vaccines mandates hepatitis B, and most do not require HPV at all. The order’s universal list and the typical state mandate list are different lists, in both directions.

The order also calls for the combined MMR to be given as three separate single-disease shots once such products are available domestically, and for childhood immunizations to be administered at separate visits to the maximum extent feasible.

Section 4

Section 4(a) directs the Attorney General to further meritorious legal actions challenging state laws that conflict with obligations concerning parental authority, religious freedom, disability accommodation and equal protection, including states’ obligations to provide religious and medical exemptions from childhood immunization requirements. Section 4(b) directs Justice, Education and HHS to ensure their contractors and grantees, states and localities included, comply with those same obligations.

On the religious side, no court has yet held that states carry such an obligation. The Supreme Court has never held that the First Amendment requires a religious exemption to a vaccine mandate, and no federal appeals court has either. Congress wrote a religious accommodation requirement into Title VII for employees and never wrote one for schoolchildren, which is why New York and Connecticut were able to repeal theirs and survive the challenges.

What has changed is Miller v. McDonald, the Amish case out of New York. Last December the Supreme Court vacated the Second Circuit’s ruling and sent it back for reconsideration under Mahmoud v. Taylor, its parental opt-out decision from June 2025. On June 30 the Second Circuit reaffirmed anyway, holding New York’s law neutral and generally applicable. Those families are out of options short of the Supreme Court, and their petition deadline runs into late September.

Six weeks after that ruling, the President directed his Attorney General to support challenges to state laws denying religious exemptions. That is a very big signal.

I do not think that sequence is coincidental. Section 4 puts the United States on the side of the exemption cases, and Miller is the one closest to the Court. That is a multi-year project rather than a ninety-day one, and if it lands, it will change more than anything else in the order.

Monday’s EO signing was a very good day for the vaccine-concerned community. It signals that the Trump administration is back on track, once again acknowledging the key problems with the U.S. vaccine industrial complex: too many shots, too many shots at one time, lack of recognition of serious adverse events, inadequate (read NO) testing of the entire schedule, and the refusal of a few states to allow religious exemptions. Whatever else you can say about the President, he’s got a pair.

Rick Jaffe, Esq.